The move makes Moderna’s vaccine, called Spikevax, the first COVID shot for kids in the U.S. to be fully approved, rather ...

How did we get here? Until now, vaccines for all children under age 12 had been available under emergency use authorization ...

The FDA this week fully approved Moderna’s COVID-19 vaccine for children aged 6 months to 11 years but limited the approval ...

Bangladesh is finally experiencing some relief. The virus has slowed down, with no new deaths or hospitalizations reported in ...

The U.S. Food and Drug Administration has granted full approval for Moderna's MRNA.O COVID-19 vaccine, Spikevax, in children aged 6 months through 11 years who are at an increased risk of the disease, ...

A new COVID-19 strain called Stratus may evade vaccine immunity, experts warn. With rising cases in the UK and unusual ...

By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site ...

Younger children will now have access to a COVID-19 vaccine — but only if they're considered at higher risk. The U.S. Food ...

Symptoms mirror Omicron’s, that is, fever, cough, fatigue, sore throat, and muscle aches. Though India’s Covid response ...

The approval of Moderna's Spikevax for kids at higher risk of contracting the disease continues the company's regulatory ...

Kennedy selected a new team of medical professionals and scientists who are looking at vaccines are highly qualified.

Novavax's growth relies on Sanofi royalties and COVID/flu vaccines, lacking innovation and clear catalysts. Click here to ...